SK Biopharmaceuticals said Monday it has received US Food and Drug Administration approval to begin a phase 1 clinical trial ...
TOKYO, Oct. 31, 2025 /PRNewswire/ -- Alpha Fusion Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Sunao Fujioka; hereinafter "Alpha Fusion") today announced the initiation of a company-sponsored Phase I ...
Isotek Systems is processing nuclear waste from Oak Ridge National Laboratory to extract a rare medical isotope. The extracted isotope, actinium-225, is used in targeted alpha therapy to destroy ...
Radiation Research, Vol. 152, No. 6, Supplement: The International Workshop on the Health Effects of Thorotrast, Radium, Radon and Other Alpha-Emitters 1999 (Dec., 1999), pp. S43-S47 (5 pages) There ...
Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission ...
Researchers at Kanazawa University report in ACS Omega a promising combination of radioisotope-carrying molecules for use in radiotheranostics — a diagnosis-and-treatment approach based on the ...
The MarketWatch News Department was not involved in the creation of this content. -- Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naïve patients with ...
– Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naïve patients with differentiated thyroid cancer – This clinical trial is designed based on the results of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback